# Investigation Log: Kenya-Nigeria Tele-PrEP Claim Analysis

> **Purpose**: This log documents my thought process during this investigation, including uncertainties, corrections, and evolving understanding. It is not meant as definitive claims, but as a transparent record of open inquiry.

---

## Entry 1: June 16, 2025 - Article Forwarded & Initial Reaction

My father's partner, who worked in AIDS research her entire career, forwarded me a Lancet HIV Comment about AI in HIV prevention. She knows I'm interested in AI in medicine and sent it with no comment - just sharing something she thought I'd find interesting. My immediate response was highly skeptical about the AI proposals. But upon closer inspection, I noticed what appeared to be concerning discrepancies: the citations didn't seem to match the claims being made. The Kenya/Nigeria AI telemedicine claim cited sources that, to my reading, didn't actually support it, and several other citations seemed potentially misrepresented as well. 

As I examined more citations, I began to worry there might be a broader pattern. For example, Citation 8 appeared to support claims about "AI chatbots, SMS reminders, and virtual self-risk assessments" offering "greater privacy, convenience, and autonomy," but the cited study seemed to evaluate only a single Montreal chatbot with 28 participants, contained no SMS component or virtual self-risk assessment, and had no comparison group to support claims about "greater" anything. 

What concerned me most was the potential real-world impact: overstating the maturity of AI-enabled PrEP delivery could mislead policy-makers and funders, potentially diverting scarce HIV prevention resources toward unvalidated technologies rather than proven interventions. Given the stakes involved in HIV prevention, I felt these discrepancies warranted closer examination. I want to acknowledge upfront that I may be misunderstanding the authors' intent or missing context that would clarify these apparent inconsistencies.

---

## Entry 2: June 17, 2025 - Direct Engagement on LinkedIn

I decided to try engaging directly with the author by commenting on their LinkedIn post promoting the paper. I wanted to give them an opportunity to clarify what appeared to be discrepancies before taking any other steps. My comment raised concerns about potential overstatement of AI capabilities and cited specific examples where the claims didn't seem to match the sources, while asking if they could clarify these points. I tried to frame this constructively, focusing on the potential impact on HIV prevention resources, though I recognize my tone may have come across as more confrontational than I intended. The author did not respond to the comment.

Here's the comment I sent:
> "Do you think your paper could unintentionally set back HIV prevention by overstating the current capabilities of AI tools? Several claims don't seem to match your cited sources, and I worry this might misdirect limited resources away from proven interventions.
> 
> For example, you write "In Kenya and Nigeria, AI powers telemedicine-based PrEP services that eliminate the need for frequent clinic visits." âµ â¶, but Ref 6 only describes a small Kenyan pilot where AI assists with photo quality checking of HIV self-testsâ€”it doesn't "power" the telemedicine services, doesn't eliminate clinical oversight, and doesn't mention Nigeria at all. Notably, this AI system was built by Audere, your own sponsor, yet you're citing it as independent evidence while overstating its capabilities. Ref 5 is a Nigerian workshop on pharmacy-based PrEP design with no AI involved.
> 
> Your paper draws its key recommendations (Ref 3) from a brief published by Audere, your own sponsor, which appears to be promotional material rather than actual research. This is exactly the type of AI hype that risks misdirecting HIV prevention resources toward unproven technologies rather than evidence-based interventions.
> 
> Given the high stakes in HIV prevention, could you clarify these discrepancies?"

The comment was deleted by the lead author.

---

## Entry 3: June 18, 2025 - Contacting The Lancet HIV

After my LinkedIn comment went unanswered, I decided to respectfully contact the journal to seek clarification about what appeared to be citation discrepancies. I raised three concerns that I hoped the authors could help clarify: what seemed to be misrepresentation of cited evidence for the Kenya/Nigeria claim, the use of sponsor material as independent evidence, and apparent scope misrepresentation in other citations. I emphasized that my goal was simply to ensure accuracy in the scientific record and that I was open to correction if I had misunderstood something. Peter Hayward responded quickly with acknowledgment that they would look into it.

---

## Entry 4: June 23, 2025 - Developing LLM Analysis

I decided to develop additional evidence to better understand the potential source of the discrepancy and created this GitHub repository with LLM reproduction tests to explore how the claim might have originated from AI summarization of the Audere whitepaper. The findings were intriguing, though I recognize they are not definitive proof: LLMs consistently produce the Kenya + Nigeria + AI claim when summarizing the Audere document, but never when summarizing the cited PATH guide. While this suggests a possible explanation for the citation mismatch, I acknowledge there could be other explanations I haven't considered. I shared this analysis with the journal, and they said they were seeking a response from the authors and would get back to me by the end of the week.

---

## Entry 5: June 25, 2025 - Author Blocks Me, Contacting Duke Integrity Office

After my LinkedIn comment went unanswered, I later discovered that the lead author had blocked me from viewing their profile before deleting my comment. I understand that researchers may receive unwanted contacts and may have reasons for limiting interactions, but this response left me unable to seek direct clarification that might have resolved my concerns. Given the potential research integrity implications and my inability to engage directly with the author, I reluctantly decided to contact Duke University's Office of Scientific Integrity, emphasizing that I hoped this could lead to clarification rather than conflict. Dr. Donna Kessler acknowledged that my concerns would be reviewed under applicable policies.

---

## Entry 6: June 29, 2025 - Expanding the Investigation

The journal said they hoped to have a response by June 27, but there's been no word yet despite my follow-up. Duke is reviewing under their policies, and the author has blocked direct communication. I believe my analysis suggests a possible explanation for the citation discrepancy - that the sentence may have originated from AI summarization of sponsor materials rather than cited sources - but I remain open to alternative explanations that I may not have considered.

Today I also spent some time reading other papers and commentary pieces by the lead author. Using the same cautious approach, I compared several headline claims with their cited references and, in multiple cases, could not find support for the statements. I have begun documenting those examples in the [pattern folder](/docs/pattern/) of this repository so that any reviewer can check my reading. This early scan strengthens my sense that the original issue may not be isolated, though I still acknowledge the possibility that I have missed context or misunderstood the authors' intent.

I also re-ran the workflow on a second disputed sentence: *"Predictive models could further enhance these programmes by helping providers identify individuals at greatest risk of HIV acquisition, forecast supply needs, and target outreach efforts more effectively.7"*  In this sentence, the first and last clauses align with Balzer et al., but the **"forecast supply needs"** clause does not appear in that study.  When the LLMs were forced to base their answer on Balzer et al., supply-forecast language never appeared (0 % hit-rate).  When supplied with the Audere sponsor white-paper, however, the same models repeated the phrase in 25â€“50 % of generationsâ€”mirroring what ended up in the Comment.  The white-paper itself cites McKinsey's 2023 State of AI survey as evidence, yet that survey actually shows supply-chain management is one of the least common and least valuable AI use-cases.  In short, the claim rests on a chain of misinterpretation: McKinsey data â†’ oversold in Audere marketing â†’ copied by an LLM â†’ published in the Comment and mis-cited to Balzer.  As a control, I also ran the prompts with *no source text at all*; supply-forecast wording appeared only occasionally (5â€“20 percent), confirming it is background knowledge for the models but far less likely to surface than when the Audere text is provided.

---

## Entry 7: June 30, 2025 - Update from the Journal

The journal responded this morning. Peter Hayward apologized for the delay and explained that, because this is the first time The Lancet HIV has encountered a case like this, he is consulting colleagues in the wider Lancet group and that due diligence is taking longer than expected. He hopes to have a full response by the end of the week. I acknowledged his update, thanked him for the ongoing review, and noted that this [one](https://github.com/ryanmio/kenya-nigeria-prep-hallucination-audit/blob/main/docs/pattern/citation7_staff_count_error.md) numerical typo could likely be addressed quickly without waiting for the broader investigation.

---

## Entry 8: July 1, 2025 - Repository Reproducibility Polish

Today I did a full pass to make the project **turn-key reproducible** for outside reviewers:

1. Re-tested every script end-to-end with `--seeds 1` to keep costs low while verifying CLI flags and output paths.
2. Refactored `scripts/analyze_results.py` so it accepts an optional directory argument (`python analyze_results.py [dir]`).  This removes the hard-coded current-dir limitation.
3. Overhauled `README.md`:
   â€¢ Clear **Quick-Start** for viewing existing results without an API key.
   â€¢ Added a single **ðŸ“‹ Full Reproduction Workflow** block that rebuilds *all* CSVs and stats in the docs, including both prompt types and all three supply-forecast conditions.

I hope with this polish any reviewer can clone the repo and regenerate every figure in the audit.

---

## Entry 9: July 2, 2025 - Conflict of Interest

Today I carefully reviewed the Lancet HIV and ICMJE guidelines for conflict-of-interest (COI) disclosure. The guidelines clearly require authors to disclose all financial and non-financial relationships from the past 36 months that could be perceived as influencing their published work. The Lancet HIV explicitly states that failure to disclose a relevant COI constitutes an error requiring correction.

I also confirmed Lancet's correction policy: they do explicitly state they do not correct simple bibliographic errors (wrong references), but they do correct misleading quoted statements that cite references out of context. This directly applies here, as the problematic sentences in question appear mis-cited rather than merely mis-referenced, clearly justifying a correction or at least published correspondence under their policy.

[Correction policy](https://www.thelancet.com/pb-assets/Lancet/authors/correction-policy-1637238881673.pdf)

---

## Entry 10: July 3, 2025 - Tracing the Claims

I have begun tracing the claims in the Lancet Comment to their source materials and evaluating the evidence for each claim, as well as the evidence of AI involvment and ultimately error.

I found some very interesting things. Most notably, a citation from the Audere white paper, which is authored by the same person as the Lancet Comment, appears to be a a combination of two separate McKinsey white papers. This is a telltale sign of AI hallucination. The citation reads:

> McKinsey Global Institute. The Future of AI in Healthcare. McKinsey & Company; 2023. Available from: https://www.mckinsey.com/capabilities/quantumblack/our-insights/the-state-of-ai-in-2023-generative-ais-breakout-year

The title of the citation is "The Future of AI in Healthcare", however the citation hyperlinks to "The state of AI in 2023: Generative AI's breakout year". Further, we can find no evidence of a McKinsey Global Institute report titled "The Future of AI in Healthcare", although we found a LinkedIn and blog post that repeat this same citation, both of which GPTzero flagged as 100% AI-generated with high confidence. This is documented in more detail in the [trace of claims](trace_of_claims.md) document.

Given that the author of the Audere white paper is the same as the author of the Lancet Comment, this is clear evidence the author has used AI during the research and/or writing of their published work before without adaquate attention to detail.

While the Audere white paper is not peer-reviewed, if the author relied on the same workflow to write the Lancet Comment, this would be a serious error that has the potential to mislead policy-makers and funders. I beleive it is important to continue looking into this angle as it could be a cautionary example for medical journals and authors.

---

## Entry 11: July 4, 2025 - Audit of Questionable Citations in Audere White-Paper

Today I drafted a standalone markdown document (`docs/audere-white-paper-citations.md`) that systematically audits five problematic references (#6, #7, #8, #10, #17) in the Audere consultation white-paper.  The write-up:

1. Presents each citation exactly as printed in the white-paper.
2. States the specific defect (fabricated title, broken link, irrelevant URL, or unverifiable document).
3. Provides transparent evidence for each claim and notes remaining uncertainties.

Although I cannot prove AI involvement without access to the authors' workflow, the pattern across multiple citations makes human transcription error increasingly unlikely.  I remain open to correction if a legitimate source surfaces.

I shared these concerns with Audere via email. To my surprise and their credit, CEO Dino Rech responded almost immediately. He very politely thanked me for bringing this to their attention and said he would look into it. He also offered to make time to discuss the report and any themes I'm concerned about. This is a very positive sign and I look forward to the conversation. In my reply, I expressed that I'm a strong advocate of AI in research, but I also believe in human oversight to catch or correct errors before they impact real-world decisions. I am very appreciative of their willingness to engage and am hopeful this will lead to a constructive conversation.

Finally, I purchased a GPTzero subscription, which allowed me to run a full audit in excess of the free tier's 5000 character limit. I have exported and committed all of the scans to the `docs/GPTZero_scans` folder. ~~I included every scan I ran, even if the result was confidently human-generated, for full transparency.~~ Note that I had to remove scans of journal entries for copyright compliance, but all other scans are included for transparency.

---

## Entry 12: July 5, 2025 - Author Responds

Yesterday afternoon (July 4) I finally received a direct email reply from one of the authors in response to the concerns I first raised on June 25.  They state that they have already sent a detailed explanation to *The Lancet HIV* editors and that they "welcomes critical engagement," but characterises my escalation to Duke University as "inappropriate and bordering on harassment." They further warn that if my "behavior continues" they will be **forced to seek legal counsel**.

I replied within thirty minutes, clarifying that:
* My critique is strictly evidence-based and unrelated to their identity, politics, or background.
* Routing potential publication-integrity issues through the journal and Duke's Office of Scientific Integrity is the *recommended* procedure, not harassment. (See [Duke's policy](https://myresearchpath.duke.edu/topics/misconduct-research) stating "Any individual with concerns about possible research misconduct should report the matter to the misconduct review officer (MRO)")
* Threatening legal action against documented, good-faith scientific critique risks chilling open discourse.

I reiterated my willingness to correct any factual misunderstandings and thanked them for their contributions.

Given the potential for legal action, I temporarily made this repo private while I reviewed and disclaimed any potential legal liability. During this review, I removed any mention of the author's name other than bylines, added legal disclaimers to several files, and removed any potentially copyrighted content.

I remain open to correcting any factual misunderstandings, and eagerly await the journal's formal response. Until then, I will continue to maintain a professional, evidence-focused tone regardless of any legal posture.

---

## Entry 13: July 7, 2025 - Response from the Journal

The journal editor responded today, agreeing to correct the misplaced Nigeria reference. They found no evidence of AI-generated text but invited me to submit a Comment on AI maturity in HIV programs.

It seems the editor may have misunderstood my experiment's focusâ€”testing AI as a research assistant introducing upstream errors, not generating final prose. Humans rarely insert random erroneous details like AI does, so I believe there's still an important lesson here for the research community.

## Entry 14: July 13, 2025 - Audere Corrections and Drafting Comment

After taking a weeklong break to disengage entirely and reapproach with fresh perspectiveâ€”the editor's response sidestepping my detailed repo took time to processâ€”today I noticed Audere has corrected several citation errors I flagged in their white paper, replacing fabricated references with realâ€”but often mismatchedâ€”ones. This strengthens my hypothesis about upstream AI involvement propagating to the Commentary. I've begun drafting my own Correspondence piece for potential submission to The Lancet HIV, focusing on AI as a misinformation vector using this as an illustrative example.

*This log will be updated as the investigation progresses. All entries reflect my thinking at the time of writing and may be revised based on new evidence.* 